Atlas FDA

COBRA PzF NanoCoated Coronary Stent System

FDA premarket approval P160014/S018 · decided 2021-10-12

Approval details

PMA number
P160014
Supplement
S018
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Labeling Change - PAS
Trade name
COBRA PzF NanoCoated Coronary Stent System
Generic name
STENT, CORONARY
Applicant
Celonova Biosciences, Inc.
Date received
2021-05-20
Decision date
2021-10-12
Days to decision
145 days
Decision code
APPR
Product code
MAF
Advisory committee
Cardiovascular
Expedited review
No
Location
San Antonio, TX
Statement
Approval for the updated final labeling to reflect the 5-year data obtained in the PzF SHIELD PAS study.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EMBOZENE COLOR-ADVANCED MICROSPHERES, EMBOZENE OPAQUE (NON-COLORED) MICROSPHERES, ONCOZENE MICROSPHERES (K141209)Celonova Biosciences, Inc.2014-08-07
EMBOZENE COLOR-ADVANCED MICROSPHERES, EMBOZENE OPAQUE (NON-COLORED) MICROSPHERES (K133447)Celonova Biosciences, Inc.2014-02-24
EMBOZENE MICROSPHERES (K132675)Celonova Biosciences, Inc.2013-10-03
ONCOZENE MICROSPHERES 40UM, 2ML, ONCOZENE MICROSPHERES 75UM, 2ML, ONCOZENE MICROSPHERES 100UM, 2ML, ONCOZENE MICROSPHERE (K130307)Celonova Biosciences, Inc.2013-03-04
EMBOZENE MICROSPHERES (K073417)Celonova Biosciences, Inc.2008-12-15